T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$2.6B |
| 2 |
BNY
Bank of New York Mellon
BNY
|
+$1.1B |
| 3 |
Elevance Health
ELV
|
+$903M |
| 4 |
DD
Du Pont De Nemours E I
DD
|
+$873M |
| 5 |
Medtronic
MDT
|
+$868M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$3.89B |
| 2 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$1.06B |
| 3 |
CFN
CAREFUSION CORPORATION
CFN
|
+$946M |
| 4 |
Aptiv
APTV
|
+$886M |
| 5 |
KSU
Kansas City Southern
KSU
|
+$662M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.05% |
| 2 | Consumer Discretionary | 13.82% |
| 3 | Financials | 13.14% |
| 4 | Industrials | 11.9% |
| 5 | Technology | 9.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1376
AutoNation
AN
$6.89B
| $8.23M | ﹤0.01% |
128,001
-20
| -0% | -$1.23K |
|
|
PBCT
1377
DELISTED
People's United Financial Inc
PBCT
| $8.21M | ﹤0.01% |
540,227
+6,780
| +1% | +$101K |
|
1378
Patterson-UTI
PTEN
$4.16B
| $8.13M | ﹤0.01% |
432,957
+386,920
| +840% | +$6.63M |
|
|
JPM.WS
1379
DELISTED
JPMorgan Chase
JPM.WS
| $8.13M | ﹤0.01% |
369,300
| – | – |
|
1380
Assurant
AIZ
$13.9B
| $8.11M | ﹤0.01% |
132,045
+4,785
| +4% | +$303K |
|
|
PGI
1381
DELISTED
PREMIERE GLOBAL SERVICES, INC.
PGI
| $8.08M | ﹤0.01% |
844,984
-218,588
| -21% | -$2.08M |
|
|
CAS
1382
DELISTED
A M Castle & Co
CAS
| $8.06M | ﹤0.01% |
2,208,799
+253,010
| +13% | +$1.3M |
|
|
XRM
1383
DELISTED
Xerium Technologies Inc (new)
XRM
| $8.03M | ﹤0.01% |
495,000
-10,000
| -2% | -$156K |
|
|
MCF
1384
DELISTED
Contango Oil & Gas Co.
MCF
| $7.96M | ﹤0.01% |
361,690
-264,591
| -42% | -$6.81M |
|
1385
First Solar
FSLR
$24B
| $7.94M | ﹤0.01% |
132,855
-222,936
| -63% | -$11.4M |
|
|
SGI
1386
Somnigroup International
SGI
$14B
| $7.92M | ﹤0.01% |
548,520
+271,160
| +98% | +$3.75M |
|
1387
Pitney Bowes
PBI
$2.28B
| $7.89M | ﹤0.01% |
338,381
| – | – |
|
1388
Berkshire Hathaway Class A
BRK.A
$1.09T
| $7.83M | ﹤0.01% |
36
| – | – |
|
|
MASI
1389
DELISTED
Masimo
MASI
| $7.81M | ﹤0.01% |
236,930
+10,400
| +5% | +$299K |
|
|
PAY
1390
DELISTED
Verifone Systems Inc
PAY
| $7.75M | ﹤0.01% |
222,202
+7,850
| +4% | +$272K |
|
1391
American Water Works
AWK
$27.1B
| $7.74M | ﹤0.01% |
142,700
+85,800
| +151% | +$4.67M |
|
|
SFLY
1392
DELISTED
Shutterfly, Inc.
SFLY
| $7.73M | ﹤0.01% |
170,900
-18,300
| -10% | -$830K |
|
|
MTCN
1393
DELISTED
ARCELORMITTAL 6% MANDATORILTY CONV SUB NT DUE 2016 (LUX)
MTCN
| $7.73M | ﹤0.01% |
513,247
+6,828
| +1% | +$113K |
|
|
CBM
1394
DELISTED
Cambrex Corporation
CBM
| $7.69M | ﹤0.01% |
194,010
+184,300
| +1,898% | +$5.45M |
|
|
ANSS
1395
DELISTED
Ansys
ANSS
| $7.67M | ﹤0.01% |
86,953
-8,546
| -9% | -$723K |
|
|
IBTX
1396
DELISTED
Independent Bank Group, Inc.
IBTX
| $7.65M | ﹤0.01% |
196,610
+1,200
| +0.6% | +$42.8K |
|
1397
Herc Holdings
HRI
$5.64B
| $7.42M | ﹤0.01% |
114,070
-1,017,403
| -90% | -$68M |
|
1398
Ligand Pharmaceuticals
LGND
$5.76B
| $7.41M | ﹤0.01% |
153,949
+15,229
| +11% | +$583K |
|
1399
Freshpet
FRPT
$3.5B
| $7.38M | ﹤0.01% |
379,840
+600
| +0.2% | +$10.1K |
|
1400
Phibro Animal Health
PAHC
$1.38B
| $7.36M | ﹤0.01% |
207,800
+100,100
| +93% | +$3.22M |
|
Similar funds
T. Rowe Price Associates's Q1 2015 Portfolio in Review
As of Q1 2015, T. Rowe Price Associates held 2,630 positions worth $484B, up 2.8% from $471B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
T. Rowe Price Associates's Q1 2015 filing shows 93 new, 1,078 increased, 887 reduced and 93 closed positions. Its largest new stake was ACTAVIS PLC Pfd Conv Ser A (Irl): 516,600 shares worth $532M. The largest sale was Allergan Inc, an estimated $3.89B.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 20% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q1 2015 buy was ACTAVIS PLC Pfd Conv Ser A (Irl): 516,600 shares worth $532M.
- T. Rowe Price Associates added most to Allergan plc in Q1 2015, an estimated $2.6B increase.
- T. Rowe Price Associates's biggest Q1 2015 reduction was Aptiv, cutting an estimated $886M.
- T. Rowe Price Associates fully exited Allergan Inc in Q1 2015, selling an estimated $3.89B.
- T. Rowe Price Associates's ten largest holdings make up 13% of its $484B portfolio in Q1 2015.
- T. Rowe Price Associates opened 93 new positions and closed 93 in Q1 2015.
- T. Rowe Price Associates's portfolio value rose 2.8% quarter-over-quarter to $484B.
Based on T. Rowe Price Associates's 13F filing for Q1 2015, filed 15 May 2015.